Patent · US Active

Activatable recombinant neurotoxins

US7959933B2 · kind B2 · utility

9Cited by

14References

12Claims

0Family size

Assignee

Allergan, Inc. · US

Inventors

J. Oliver Dolly · Cheam, GB
Yan Li · Tallahassee, US
Kuo Chion Chan · London, GB

Key dates

Filing date	Jul 30, 2008
Grant date	Jun 14, 2011
Priority date	—
Expiry date	Dec 1, 2028

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Compositions comprising activatable recombinant neurotoxins and polypeptides derived therefrom. The invention also comprises nucleic acids encoding such polypeptides, and methods of making such polypeptides and nucleic acids.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.